When a vaccine must transition from idea to clinic, every step that reduces variability and accelerates scale-up matters. Vero cells — an anchor of modern virology and vaccine manufacture — are the workhorse many developers choose because they’re permissive to diverse viruses, well characterised for regulatory use, and readily grown on microcarriers for scale. At… Continue reading Vero-cell vaccine production: why Vero cells — and the right media — power faster, safer vaccine pipelines